<img title="rep pic" src="https://images.mid-day.com/images/2017/jan/inflammatory-arthritis.jpg" alt="rep pic" width="670" height="447" /> A common rheumatoid arthritis drug may be an effective new therapy for lowering blood glucose levels in patients with Type-2 diabetes, according to a study.
Rheumatoid arthritis, affecting approximately one per cent of the worldwide population, is a chronic autoimmune condition that causes pain and swelling in the joints.
The anti-inflammatory drug, lefluonamide, lowered blood glucose levels and reversed insulin resistance in mouse models of Type 2 diabetes, which suggests that this therapy could be repurposed as an effective antidiabetic treatment, particularly suitable for patients with both diabetes and rheumatoid arthritis.
"We found that lefluonomide targets a protein involved in desensitising the insulin receptor, which is responsible for instructing the cells to start absorbing sugar from the bloodstream", said Xiulong Xu, Professor at the Institute of Comparative Medicine at Yangzhou University in China.
Lefluonamide has long been approved to treat rheumatoid arthritis and previous clinical studies have noted that patients taking the drug tended to have lower blood glucose levels and that obese patients lost weight.
However, lefluonomide also acts on other molecular targets in the body. This suggests that more studies are needed to confirm that the anti-diabetic effects observed are solely caused by lefluonamide's effect on the insulin receptor.
"We know some inflammatory factors can also desensitise the insulin receptor, and lefluonamide is an anti-inflammatory, so it may be that it controls blood sugar partly by its anti-inflammatory effect," Xu said, in a paper published in the Journal of Endocrinology.
The next step for Xu is to conduct clinical trials to test if the antidiabetic effect of lefluonamide also occurs in humans as well as mice.
Catch up on all the latest <a title="mid-day news" href="https://www.mid-day.com/news" target="_blank">Crime, National, International and Hatke news</a> <a href="https://www.mid-day.com/news" target="_blank">here</a>. Also download the new mid-day <a title="mid-day android app " href="https://goo.gl/8Xlcvr" target="_blank">Android</a> and <a title="mid-day iOS app" href="https://goo.gl/KQziH4" target="_blank">iOS</a> apps to get latest updates
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

Rheumatoid arthritis, affecting approximately one per cent of the worldwide population, is a chronic autoimmune condition that causes pain and swelling in the joints

Arthritis drug may help lower blood sugar levels

Trending Stories

Latest Photos

Latest Videos

Latest Web Stories

Mid-Day Fast

Home / Lifestyle / Health & Fitness / Article / Arthritis drug may help lower blood sugar levels

Arthritis drug may help lower blood sugar levels

Trending Stories

Latest Photos

Latest Videos

Latest Web Stories

Mid-Day Fast